PRESS RELEASE PRINCETON, N.J efter en kraftig måltid .—-Bristol-Myers Squibb Business today announced that it received the Prix Galien USA 2015 Award for Best Biotechnology Product forOpdivo, the Business’s PD-1 immune checkpoint inhibitor. Bristol-Myers Squibb was identified for its innovative discovery and development ofOpdivoin accepted indications for previously treated metastatic squamous non-small cell lung cancer , and in unresectable or metastatic melanoma and disease progression followingYervoy and, ifBRAFV600 mutation positive, aBRAFinhibitor, for which itreceived accelerated approval based on tumor response durability and rate of response. Since the submission for the Best Biotechnology Award,Opdivohas been approved by the U also.S.

Other articles from category "nutrition":

Random articles